BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2936417)

  • 1. A 5 year follow-up of Dacron femoropopliteal bypass grafts.
    Mosley JG; Marston A
    Br J Surg; 1986 Jan; 73(1):24-7. PubMed ID: 2936417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft type for femoro-popliteal bypass surgery.
    Mamode N; Scott RN
    Cochrane Database Syst Rev; 2000; (2):CD001487. PubMed ID: 10796649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between saphenous vein and Dacron Velour grafts for femoropopliteal bypass.
    Harris J; May J
    Aust N Z J Surg; 1979 Apr; 49(2):211-4. PubMed ID: 157125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New technique for construction of coposite Dacron vein grafts for femoro-distal popliteal bypass in the severely ischemic leg.
    Lord JW; Sadranagani B; Bajwa G; Rossi G
    Ann Surg; 1975 May; 181(5):670-5. PubMed ID: 124161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Hohman S; Pearl G; Theune B
    J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-bonded Dacron or polytetrafluorethylene for femoropopliteal bypass: five-year results of a prospective randomized multicenter clinical trial.
    Devine C; McCollum C;
    J Vasc Surg; 2004 Nov; 40(5):924-31. PubMed ID: 15557906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
    McQuade K; Gable D; Pearl G; Theune B; Black S
    J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Femoropopliteal bypass vs percutaneous transluminal angioplasty and stenting in treatment of peripheral artery diseases of infrainquinal segment - short-term results.
    Cvetanovski MV; Jovev S; Cvetanovska M; Blazevski B; Colanceski R; Andreevska T; Gramatnikovski N; Kartalov A
    Prilozi; 2009 Jul; 30(1):105-18. PubMed ID: 19736534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the diameter of the vein graft and postoperative ankle brachial pressure index following femoro-popliteal bypass.
    Matsushita M; Ikezawa T; Banno H
    Int Angiol; 2008 Aug; 27(4):329-32. PubMed ID: 18677296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polytetrafluoroethylene use for above-knee femoropopliteal bypass in critical limb ischemia.
    El-Kayali AA
    Saudi Med J; 2003 Jun; 24(6):669-71. PubMed ID: 12847601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term results of 66 femoral-to-femoral by-pass grafts: a 9-year follow-up.
    Mosley JG; Marston A
    Br J Surg; 1983 Oct; 70(10):631-4. PubMed ID: 6626926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A five- to seven-year experience with externally-supported Dacron prostheses in axillofemoral and femoropopliteal bypass.
    Schultz GA; Sauvage LR; Mathisen SR; Mansfield PB; Smith JC; Davis CC; Hall DG; Rittenhouse EA; Kowalsky TE
    Ann Vasc Surg; 1986 Sep; 1(2):214-24. PubMed ID: 2973796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Femoropopliteal bypass with a compliant, composite polyurethane/Dacron graft: short-term results of a multicentre trial.
    Dereume JP; van Romphey A; Vincent G; Engelmann E
    Cardiovasc Surg; 1993 Oct; 1(5):499-503. PubMed ID: 8076085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sparks mandril, velour Dacron and autogenous saphenous vein grafts in femoropopliteal bypass.
    Christenson JT; Eklöf B
    Br J Surg; 1979 Jul; 66(7):514-7. PubMed ID: 157181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Below knee femoropopliteal bypass in severe ischaemia: results using EXS Dacron and human umbilical vein.
    Clifford PC; Gazzard V; Lawrance RJ; Clyne CA; Webster JH
    Ann R Coll Surg Engl; 1986 Nov; 68(6):319-22. PubMed ID: 2949686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Debatable Choice of Iliac Inflow Source for Redo Femoropopliteal and Infrapopliteal Bypass.
    Gabrielli R; Ciocca F; Dante A; Musilli A; Maiorano M; Ventura M
    Ann Vasc Surg; 2018 Oct; 52():316.e15-316.e19. PubMed ID: 29886210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dacron vs vein for femoropopliteal arterial bypass. Should the saphenous vein be spared?
    Yashar JJ; Thompson R; Burnard RJ; Weyman AK; Yashar J; Hopkins RW
    Arch Surg; 1981 Aug; 116(8):1037-40. PubMed ID: 6455108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A contemporary meta-analysis of Dacron versus polytetrafluoroethylene grafts for femoropopliteal bypass grafting.
    Takagi H; Goto SN; Matsui M; Manabe H; Umemoto T
    J Vasc Surg; 2010 Jul; 52(1):232-6. PubMed ID: 20471778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.